cover
Contact Name
Rachmat Hidayat
Contact Email
dr.rachmat.hidayat@gmail.com
Phone
+6288225053819
Journal Mail Official
scientiapsychiatrica@gmail.com
Editorial Address
Dr. Moh Ali street
Location
Kota palembang,
Sumatera selatan
INDONESIA
Scientia Psychiatrica
Published by HM Publisher
ISSN : -     EISSN : 27159736     DOI : https://doi.org/10.37275/scipsy
Core Subject : Health, Science,
Scientia Psychiatrica covers the latest developments in various fields of psychiatric : biological psychiatry, neuropsychiatry, child psychiatry, psychiatry of community, psychotherapy, drugs-related mental illness, psychiatry of geriatric, psychosomatics medicine, psychology, cultural psychiatry, military psychiatry, forensic psychiatry, consultation liaison psychiatry and all medicine fields related psychiatry. Genetics, immunology, environmental health, toxicology, bioinformatics and biotechnology as well as multidisciplinary studies. The views of experts on current advances in nanotechnology and molecular/cell biology will be also considered for publication as long as they have a direct clinical impact of psychiatry.
Articles 5 Documents
Search results for , issue "Vol. 4 No. 4 (2023): Scientia Psychiatrica" : 5 Documents clear
Psychiatric Comorbidities in Children with Obesity Randy Pangestu
Scientia Psychiatrica Vol. 4 No. 4 (2023): Scientia Psychiatrica
Publisher : HM Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37275/scipsy.v5i1.60

Abstract

Childhood obesity is a significant public health issue in the 21st century. Scientists have shown interest in studying the effects of childhood obesity on several aspects of health. Obesity comorbidities encompass more than just physical issues. The effects of juvenile obesity are far-reaching and include psychological comorbidities. The objective of this review was to specifically examine the psychiatric comorbidities that are linked to pediatric obesity. A comprehensive search was performed in PubMed to identify articles that provide information on the coexistence of pediatric obesity and other medical conditions. The pertinent data were retrieved and reviewed in a narrative manner. Research has shown that childhood obesity is linked to psychological comorbidities, including depression, reduced perceived health-related quality of life, emotional and behavioral issues, and lower self-esteem during childhood.
The Impact of Anxiety and Depression on Individuals with Smoking Habit Dian Cahaya Utami
Scientia Psychiatrica Vol. 4 No. 4 (2023): Scientia Psychiatrica
Publisher : HM Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37275/scipsy.v4i4.96

Abstract

Anxiety and depressive disorder is a prevalent mental health disorder on a global scale, often exhibiting a high comorbidity rate with smoking behavior. This present review offers a comprehensive narrative synthesis of the latest scholarly studies pertaining to the influence of anxiety and depression on the onset, perpetuation, and cessation of smoking behavior. The existing literature exhibits variability in terms of the evidence supporting the association between anxiety or anxious symptoms and smoking behavior. The findings consistently indicate a significant association between anxiety and smoking, suggesting a high comorbidity rate between these two illnesses. The existing literature on the association between anxiety, depression and various factors such as onset, severity indicators, and cessation outcomes has yielded inconsistent findings. While there exists compelling data supporting the association between smoking and anxiety, notable distinctions may be observed regarding the specific impact of anxiety on the beginning, severity, and quitting outcomes of smoking. In the future, it will be necessary to employ more advanced approaches in order to ascertain causative relationships, as well as potential moderators and mediators, within the association between anxiety, depression and smoking habit.
The Role of Neurotransmitters in Relation to Psychiatric Conditions Throughout the COVID-19 Epidemic Safitri Muhlisa
Scientia Psychiatrica Vol. 4 No. 4 (2023): Scientia Psychiatrica
Publisher : HM Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37275/scipsy.v4i3.116

Abstract

Various studies have reported the presence of psychiatric symptoms among individuals diagnosed with COVID-19, encompassing heightened stress levels, impaired cognitive function, depressive mood, anxiousness, post-traumatic stress disorder (PTSD), psychotic symptoms, and suicidal ideation. The objective of this review was to elucidate the involvement of neurotransmitters in psychiatric disorders following the COVID-19 pandemic. There are multiple variables that can influence the results of research studies examining the presence of symptoms or the initiation of psychiatric disorders in individuals diagnosed with COVID-19. Factors associated with mental health difficulties include direct involvement in the healthcare field, presence of a psychiatric disease within the family, limited social support, advanced age, solitary living arrangements, and the utilization of high dosages of steroids during the acute phase. Multiple types of neurotransmitters are involved in the modulation of stress levels inside the human body. The neurotransmitters implicated in this process include dopamine, serotonin, epinephrine and norepinephrine, acetylcholine, gamma-aminobutyric acid (GABA), and glutamate. In summary, cytokines have a pivotal role in modulating the hypothalamic-pituitary-adrenal (HPA) axis within the brain, hence potentially giving rise to psychiatric manifestations including impaired sleep, heightened stress, depressive affect, and several other psychological disturbances.
Psychiatric Disturbances in Patients and Relatives Due to Intensive Care Admission Ignatius Aldo Winardi
Scientia Psychiatrica Vol. 4 No. 4 (2023): Scientia Psychiatrica
Publisher : HM Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37275/scipsy.v4i4.134

Abstract

The issue of psychiatric disorders arising from the admission of inpatient patients and their relatives has persisted for a significant period of time. This phenomenon may occur as a result of psychological trauma experienced by either the patient or their family. The majority of the family members experience fear and anxiety around the potential loss of their loved ones. Recent research has indicated that a significant proportion, ranging from 51% to 69%, of individuals within familial relationships exhibit this particular occurrence. Outpatient cardiac arrest (OCA) is recognized as a highly influential occurrence in precipitating this psychological phenomenon. The management of critically ill patients in the intensive care unit (ICU) presents a complex and demanding task. The individual's status undergoes quick and unpredictable fluctuations. The presence of ambiguity gives rise to the development of delirium, which is characterized as a state of acute brain malfunction and is observed in 50–80% of patients in the intensive care unit (ICU). The phenomenon is also correlated with prolonged hospitalizations and increased mortality rates. This review was aimed to described psychiatric disturbances in patients and relatives due to ICU admission.
The Clinical Characteristics, Neurobiology, and Treatment Options for Trichotillomania Wenty Septa Aldona
Scientia Psychiatrica Vol. 4 No. 4 (2023): Scientia Psychiatrica
Publisher : HM Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37275/scipsy.v4i4.137

Abstract

Trichotillomania is characterized by the compulsive act of pulling one's own hair, leading to hair loss and potentially causing functional impairment. Trichotillomania, a psychiatric disorder characterized by the compulsive need to pull out one's own hair, has been documented in the medical literature since the 19th century. Based on prevalence surveys, trichotillomania exhibits a notable presence throughout the population, with point prevalence estimates ranging from 0.5 to 2.0 percent. Trichotillomania, as delineated in the Diagnostic and Statistical Manual of Mental Disorders-5, is categorized as an obsessive-compulsive disorder (OCD); nonetheless, it exhibits notable distinctions from OCD across various dimensions. For instance, the use of habit reversal therapy and the administration of drugs like n-acetylcysteine or olanzapine are common ways to treat trichotillomania. It is important to note that these treatment approaches are not typically employed for the treatment of obsessive-compulsive disorder (OCD). In contrast, it appears that specific first-line medications for obsessive-compulsive disorder (such as selective serotonin reuptake inhibitors) do not demonstrate efficacy in treating trichotillomania. This article provides an overview of the existing body of knowledge pertaining to trichotillomania, a psychiatric disorder characterized by compulsive hair pulling. It also examines the available empirical evidence that supports various treatment approaches for this condition.

Page 1 of 1 | Total Record : 5